Rivercyte partners with leading institutions on innovative neonatal diagnostics project

Rivercyte is excited to announce its participation in the joint research project SoPhyA, supported by the Bavarian State Ministry for Economic Affairs, Regional Development and Energy through the BayVFP scheme. Over the next three years, Rivercyte will collaborate with the University Hospital Erlangen and the Max Planck Institute for the Science of Light to develop cutting-edge technology aiming at enhancing neonatal diagnostics.

The primary focus of the SoPhyA project is to advance the knowledge about the mechanical properties of blood cells of pediatric patients through the generation of new data and algorithms. The developments will be based on deformability cytometry, a revolutionary technique for the fast physical phenotyping of cells. This innovative approach will improve blood analysis capabilities, providing healthcare professionals with critical insights into patient health. By leveraging advanced software solutions, the partnership aims to facilitate early detection of potential health issues, ultimately leading to better outcomes in neonatal care.

As part of this collaboration, thanks to the generous BayVFP support of 319 000 EUR, Rivercyte is committed to pushing the boundaries of medical technology and contributing to the field of life sciences.

Together with our partners, we are shaping the future of neonatal diagnostics. We look forward to sharing our progress and insights as the project unfolds. Stay tuned for updates on our journey!